跳至主要内容
临床试验/NCT02382679
NCT02382679终止不适用

Vitamin Therapy in Concussion Management: A Randomized Control Trial

Thomas Jefferson University0 个研究点目标入组 20 人开始时间: 2015年3月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
20
主要终点
PCSI: Post-Concussion Symptom Inventory

研究概览

简要总结

The purpose of this study is to assess the efficacy of vitamin therapy in concussion when compared to placebo with respect to multiple endpoints including symptom severity, cognitive performance on computer based neuropsychological testing, post-concussion balance assessment, and post-concussion vestibular-oculomotor function.

详细描述

To date, very little data exists on the use of vitamin supplementation to aid in the recovery of concussion. Data previously published shows potential benefit of certain vitamins in the management of migraine headache. These vitamins, Vitamin B2 (Riboflavin), Magnesium, Co-Enzyme Q-10, and Omega-3 fatty acids, at dosages described in the literature, are being used based on the migraine literature findings and anecdotal evidence to help treat complaints of headache in concussion management.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
11 Years 至 22 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects ages 11-22
  • Concussion within 7 days of enrollment
  • Presenting for treatment at Rothman Institute or Jefferson Concussion Center

排除标准

  • Subjects with recent prior concussion within the past 30 days
  • Subjects with a history of moderate to severe TBI requiring hospitalization or resulting in prolonged symptoms (>3weeks).
  • Subjects with known neurologic diagnosis associated with impaired cognitive function other that Attention Deficit Hyperactive Disorder or Attention Deficit Disorder.
  • Subjects with know allergy to algae, omega-3 fatty acid, or any component of the formulation.
  • Subjects currently requiring anticoagulants (ie- Warfarin), anti-platelets (ie- Aspirin, Plavix), or any non-steroidal anti-inflammatory drugs (ie- Ibuprofen, Naprosyn).
  • Subjects with known liver pathology or significantly elevated liver function tests (greater than 3 X normal).
  • Subjects with a current lower extremity injury that will affect postural stability testing.
  • Subjects who are pregnant and/or breast feeding.

结局指标

主要结局

PCSI: Post-Concussion Symptom Inventory

时间窗: 4 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验